Wiley Blackwell

SHERPA: Unknown

People

  1. Gonen
    Gonen
  2. Panageas
    Panageas
  3. Seshan
    Seshan
  4. Begg
    Begg
  5. Chou
    Chou
  6. Zhang
    Zhang
  7. Capanu
    Capanu
  8. Hudis
    Hudis
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Biostatistics Service (310)
  2. Epidemiology and Biostatistics (310)
  3. Department of Medicine (179)
  4. Solid Tumor Oncology Division (146)
  5. Population Sciences Research Program (135)
  6. Survivorship Research (135)
  7. Surgery (116)
  8. Center for Pancreatic Cancer Research (113)
  9. Department of Pathology and Laboratory Medicine (70)
  10. GSK Faculty (64)
Search Within
  1. "Biostatistics Service"
Formats
  1. Journal Article (278)
  2. Meeting Abstract (30)
  3. Book Section (1)
  4. Research Letter (1)
Groups
  1. Biostatistics Service (310)
  2. Epidemiology and Biostatistics (310)
  3. Department of Medicine (179)
  4. Solid Tumor Oncology Division (146)
  5. Population Sciences Research Program (135)
  6. Survivorship Research (135)

More Groups

People
  1. Mithat Gonen (41)
  2. Katherine Panageas (38)
  3. Sujata Patil (33)
  4. Marinela Capanu (31)
  5. Venkatraman Seshan (28)
  6. Colin Begg (27)

More People

Years
  1. 2025 (5)
  2. 2024 (5)
  3. 2023 (16)
  4. 2022 (9)
  5. 2021 (13)
  6. 2020 (21)

More Years

Publications
  1. Cancer (153)
  2. Biometrics (27)
  3. Journal of Surgical Oncology (25)
  4. Hematological Oncology (21)
  5. Cancer Medicine (16)
  6. BJU International (7)

More Publications

Results (310)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes
    Journal Article

    Lowery, M. A.; Goff, L. W.; Keenan, B. P.; Jordan, E.; Wang, R.; Bocobo, A. G.; Chou, J. F.; O’Reilly, E. M.; Harding, J. J.; Kemeny, N.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
    Journal Article

    Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Changes in the multidisciplinary management of rectal cancer from 2009 to 2015 and associated improvements in short-term outcomes
    Journal Article

    Roxburgh, C. S. D.; Strombom, P.; Lynn, P.; Cercek, A.; Gonen, M.; Smith, J. J.; Temple, L. K. F.; Nash, G. M.; Guillem, J. G.; Paty, P. B.; more...
    Colorectal Disease (2019)

    Fulltext@MSK | Save
  • Real‐world assessment of practice efficiency with the introduction of subcutaneous rituximab
    Meeting Abstract

    Matasar, M. J.; Qiu, A.; Shapouri, S.; Drill, E. N.; Schade, J.; Ravelo, A.; Ni, A.; To, T. M.; Dawson, K. L.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation impacts on immune evasive mechanisms in relapsed/refractory diffuse large B‐cell lymphoma – A single center experience
    Meeting Abstract

    Sauter, C. S.; Lin, R. J.; Ho, C.; Devlin, S. M.; Maloy, M. A.; Perales, M.; Dahi, P. B.; Schoder, H.; Jakubowski, A. A.; Barker, J. N.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical significance and outcomes in patients with diffuse large B‐cell lymphoma (DLBCL) harboring extra copies [EC] and/or translocations [TL] of MYC, BCL2, and BCL6
    Meeting Abstract

    Sermer, D.; Bobillo, S.; Seshan, V.; Dogan, A.; Younes, A.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Safety and early data from a phase II trial of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (Hl) and follicular lymphoma (FL)
    Meeting Abstract

    Sermer, D.; Vardhana, S.; Batlevi, C.; Hamilton, A.; Moskowitz, A.; Caron, P.; Moskowitz, C.; Matasar, M.; Biggar, E.; Leung, E.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Impact of pet imaging and histologic transformation on the prognosis of early disease progression in follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Hamlin, P.; Horwitz, S. M.; Kumar, A.; Matasar, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Risk of breast implant associated anaplastic large cell lymphoma (BIA‐ALCL) in a cohort of 3546 women prospectively followed after receiving textured breast implants
    Meeting Abstract

    Ghione, P.; Cordeiro, P. G.; Ni, A.; Hu, Q.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S. M.
    Hematological Oncology (2019)

    Fulltext@MSK | Save